Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

StatusCompleted
PhasePhase 3
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications expanded, about 67 wordsv15
  2. Re-verified, no change to tracked fieldsv14
  3. Trial status: Active, Not Recruiting to Completed
    • Primary and study completion dates changed from estimate of Dec 2009 to Nov 2009
    v13
  4. Primary endpoints: 3 to 1
    • Enrollment target: estimated 100 to confirmed 70
    • Interventions: efavirenz (Drug), emtricitabine (Drug), tenofovir (Drug) to efavirenz (Drug), emtricitabine (Drug), tenofovir DF (Drug)
    • Secondary endpoints revised (10)
    v12
  5. Study title expanded, about 1 wordv11
Show 9 earlier versionsHide 9 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: Dec 2009
    • Site details revised
    v10
  2. 4 versions Re-verified since Aug 28, 2006, no change to tracked fieldsv6-v9
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jan 2006
    • Site details revised
    v5
  4. Study Identification, Study Statusv4
  5. 2 versions Re-verified since Jul 18, 2005, no change to tracked fieldsv2-v3
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Successful therapy of both tuberculosis and HIV disease share similar problems: pill burden, drug interaction, adherence challenge and toxicity. This study will test the efficacy and safety of a once daily antiretroviral regimen in HIV-tuberculosis coinfected patients.
Trial Details
NCT Number NCT00115609
Lead Sponsor French National Agency for Research on AIDS and Viral Hepatitis
Conditions
(from sponsor)		 HIV Infections, Tuberculosis
Related terms HIV Infections, Tuberculosis
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov